![]() | Up a level |
Journal Article
Cramer, P., Chanan-Khan, A., Demirkan, F., Fraser, G., Santucci Silva, R., Pylypenko, H., Grosicki, S., Janssens, A., Pristupa, A., Mayer, J., Dilhuydy, M. S., Loscertales, J., Bartlett, N. L., Avigdor, A., Rule, S., Sun, S., Mahler, M., Salman, M., Howes, A. and Hallek, M. (2015). IBRUTINIB COMBINED WITH BENDAMUSTINE/RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): FIRST RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY. Haematologica, 100. S. 55 - 57. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Fraser, G., Cramer, P., Demirkan, F., Santucci Silva, R., Grosicki, S., Janssens, A., Mayer, J., Dilhuydy, M. S., Pylypenko, H., Loscertales, J., Goy, A., Avigdor, A., Rule, S., Phelps, C., Mahler, M., Salman, M., Howes, A. and Hallek, M. (2016). IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY. Haematologica, 101. S. 150 - 152. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Goede, V., Fischer, K., Busch, R., Engelke, A., Eichhorst, B., Wendtner, C. M., Chagorova, T., Dela Serna, J., Dilhuydy, M. S., Opat, S., Owen, C. J., Samoylova, O., Kreuzer, K. A., Langerak, A. W., Ritgen, M., Stilgenbauer, S., Doehner, H., Asikanius, E., Humphrey, K., Wenger, M. K. and Hallek, M. (2014). Obinutuzumab (GA101) plus chlorambucil (Clb) versus rituximab plus Clb in patients with chronic lymphocytic leukaemia (CLL) and comorbidities: recently published results of the CLL11 trial. Br. J. Haematol., 165. S. 19 - 20. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141